Archive | UKDDC News

Academic Screening Group Meeting – 17th January 2017

Event title:  Academic Screening Group Meeting Date:  17th January 2017 Registration and coffee:  9 am Start: 9.30 am Agenda coming soon…. For more info please contact Linda Parkes at   Venue address:  GSK Lecture Theatre, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts SG1 2FX

Continue Reading

Drug Discovery 2016 – 13 & 14 October 2016

Conference Directors Del Trezise (Essen Biosciences), Rachel Grimley (AstraZeneca) and Chas Bountra (SGC, Oxford University) are pleased to announce the 10th Anniversary celebration of Drug Discovery which will be held this year in Liverpool at the Echo Arena. Once again, this meeting will bring together the leading lights in drug discovery research across pharma, biotech, […]

Continue Reading

Biannual meeting – 26 & 27 October 2015, London

About this event: The second Academic Screening group of 2015 is taking place over two half days on the 26th and 27th of October and is organised and hosted by CRT in central London. As with our previous ASG meetings we are expecting the presentations to be a mix of science and technical experiences, exploring […]

Continue Reading

Drug Discovery 2015

Delegate registration is FREE OF CHARGE for Drug Discovery 2015, ELRIG UK’s largest annual event. This two day meeting, divided into eight scientific tracks, brings together over 1500 delegates and 100 world-class speakers from academia and industry to discuss critical areas in drug discovery. This year’s 9th Annual Drug Discovery conference will be held on […]

Continue Reading

Biannual meetings

The last meeting took place on 11-12th May 2015 and was hosted by the Dundee Drug Discovery Unit. Presentations were given by scientists from Institute for Cancer Research, Dundee Drug Discovery Unit, Beatson Research Institute, Cancer Research Technology, University of Edinburgh, and MRC Technology.

Continue Reading

Academic Drug Discovery within the UK – a reassessment

This article provides a comprehensive summary of the capabilities, funding sources and disease indications addressed by 24 drug discovery facilities in the UK. Strategic alliances between academia, the pharmaceutical industry and the UK government exemplify the high esteem in which drug discovery in academic and not-for-profit environments is held.

Continue Reading
- Enter Your Location -
- or -